Archives
- PharmEnable raises $7.5M in Pre-Series A funding round with a follow-on investment from o2h Ventures 29 May, 2023
- Is Investing in SEIS ventures risky? – Join the o2h Chaitime Webinar 10 May, 2023
- Tay Therapeutics, an o2h Ventures portfolio company secures a licensing deal worth over $65 million 5 May, 2023
- o2h Ventures deals pipeline, Knowledge-intensive EIS Fund closing on 5th April 2023 1 March, 2023
- Oct 2022, o2h Ventures Fund Newsletter, KI EIS Closing, EISA events 1 November, 2022
- Aug-Sept 2022, o2h Ventures Fund Newsletter, fifty percent of our companies led by female and more portfolio updates 30 September, 2022
- July 2022, o2h Ventures Fund Newsletter, Deals executed in Alevin Therapeutics, Neurofenix, Five Alarm Bio 1 August, 2022
- May 2022, o2h Ventures Fund Newsletter, SEIS fund close deadline June 30th 2022 28 May, 2022
- o2h Ventures Deal Pipeline, KI EIS Fund closing on 5th April 2022 22 March, 2022